Skip to main content

Transforming the understanding
and treatment of mental illnesses.

Celebrating 75 Years! Learn More >>

 Archived Content

The National Institute of Mental Health archives materials that are over 4 years old and no longer being updated. The content on this page is provided for historical reference purposes only and may not reflect current knowledge or information.

Using Stem Cell-Based Assays for Biological and Drug Discovery Workshop


November 17–18, 2016


Bethesda, MD

The NIMH Division of Neuroscience and Basic Behavioral Science convened a workshop of scientists involved in several ongoing NIMH-funded research efforts involving human induced pluripotent stem cells (iPSCs) or similar reprogrammed cell assays. Participants represented the National Cooperative Reprogrammed Cell Research Groups  (NCRCRG), PsychENCODE, the Psychiatric Gene Networks  initiative, the Brain Somatic Mosaicism  initiative, and the NIH Common Fund Tissue Chip Consortium , along with a large number of investigator-initiated projects. This workshop offered opportunities to discuss areas of emerging progress, opportunity, or need.  Speakers discussed current practical strengths and weaknesses of using patient cell line collections versus genetically engineered isogenic cell lines to identify genetically complex psychiatric disease mechanisms. They also discussed measures needed to assess iPSC-derived cell-type fidelity and physiological relevance to their in vivo counterparts, along with current progress and need for improved cell assay technologies. Finally, there was an update on data coordination, collaboration, and data harmonization to advance biological and therapeutics discovery for mental illnesses. Organizers are developing a summary of recommendations from this third NIMH iPSC grantees workshop, which will be made available to the scientific community.